 | • レポートコード：MRC2-11QY07243 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、153ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は脂質低下剤のグローバル市場について調査・分析したレポートです。種類別（ナイアシン、アシピモックス、フィブラート、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別脂質低下剤の競争状況、市場シェア ・世界の脂質低下剤市場：種類別市場規模 2015年-2020年（ナイアシン、アシピモックス、フィブラート、その他） ・世界の脂質低下剤市場：種類別市場規模予測 2021年-2026年（ナイアシン、アシピモックス、フィブラート、その他） ・世界の脂質低下剤市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の脂質低下剤市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の脂質低下剤市場分析：米国、カナダ ・ヨーロッパの脂質低下剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの脂質低下剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の脂質低下剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの脂質低下剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Merck、Teva、Amgen、Abbott、AstraZeneca、Novartis、SUN Pharma、Torrent Pharmaceuticals、GlaxoSmithKline、HanAll BioPharma、JX Pharmaceuticals、Aurobindo Pharma、Abbvie、Cerenis Therapeutics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Lipid-lowering Agent Market
The global Lipid-lowering Agent market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Lipid-lowering Agent Scope and Market Size
Lipid-lowering Agent market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lipid-lowering Agent market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Lipid-lowering Agent market is segmented into
Niaci
Acipimox
Fibrates
Others
Segment by Application, the Lipid-lowering Agent market is segmented into
Hospitals
Clinics
Others
Regional and Country-level Analysis
The Lipid-lowering Agent market is analysed and market size information is provided by regions (countries).
The key regions covered in the Lipid-lowering Agent market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Lipid-lowering Agent Market Share Analysis
Lipid-lowering Agent market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Lipid-lowering Agent business, the date to enter into the Lipid-lowering Agent market, Lipid-lowering Agent product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Merck
Teva
Amgen
Abbott
AstraZeneca
Novartis
SUN Pharma
Torrent Pharmaceuticals
GlaxoSmithKline
HanAll BioPharma
JX Pharmaceuticals
Aurobindo Pharma
Abbvie
Cerenis Therapeutics
1 Study Coverage
1.1 Lipid-lowering Agent Product Introduction
1.2 Market Segments
1.3 Key Lipid-lowering Agent Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Lipid-lowering Agent Market Size Growth Rate by Type
1.4.2 Niaci
1.4.3 Acipimox
1.4.4 Fibrates
1.4.5 Others
1.5 Market by Application
1.5.1 Global Lipid-lowering Agent Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Lipid-lowering Agent Market Size, Estimates and Forecasts
2.1.1 Global Lipid-lowering Agent Revenue 2015-2026
2.1.2 Global Lipid-lowering Agent Sales 2015-2026
2.2 Global Lipid-lowering Agent, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Lipid-lowering Agent Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Lipid-lowering Agent Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Lipid-lowering Agent Competitor Landscape by Players
3.1 Lipid-lowering Agent Sales by Manufacturers
3.1.1 Lipid-lowering Agent Sales by Manufacturers (2015-2020)
3.1.2 Lipid-lowering Agent Sales Market Share by Manufacturers (2015-2020)
3.2 Lipid-lowering Agent Revenue by Manufacturers
3.2.1 Lipid-lowering Agent Revenue by Manufacturers (2015-2020)
3.2.2 Lipid-lowering Agent Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Lipid-lowering Agent Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Lipid-lowering Agent Revenue in 2019
3.2.5 Global Lipid-lowering Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Lipid-lowering Agent Price by Manufacturers
3.4 Lipid-lowering Agent Manufacturing Base Distribution, Product Types
3.4.1 Lipid-lowering Agent Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Lipid-lowering Agent Product Type
3.4.3 Date of International Manufacturers Enter into Lipid-lowering Agent Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Lipid-lowering Agent Market Size by Type (2015-2020)
4.1.1 Global Lipid-lowering Agent Sales by Type (2015-2020)
4.1.2 Global Lipid-lowering Agent Revenue by Type (2015-2020)
4.1.3 Lipid-lowering Agent Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Lipid-lowering Agent Market Size Forecast by Type (2021-2026)
4.2.1 Global Lipid-lowering Agent Sales Forecast by Type (2021-2026)
4.2.2 Global Lipid-lowering Agent Revenue Forecast by Type (2021-2026)
4.2.3 Lipid-lowering Agent Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Lipid-lowering Agent Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Lipid-lowering Agent Market Size by Application (2015-2020)
5.1.1 Global Lipid-lowering Agent Sales by Application (2015-2020)
5.1.2 Global Lipid-lowering Agent Revenue by Application (2015-2020)
5.1.3 Lipid-lowering Agent Price by Application (2015-2020)
5.2 Lipid-lowering Agent Market Size Forecast by Application (2021-2026)
5.2.1 Global Lipid-lowering Agent Sales Forecast by Application (2021-2026)
5.2.2 Global Lipid-lowering Agent Revenue Forecast by Application (2021-2026)
5.2.3 Global Lipid-lowering Agent Price Forecast by Application (2021-2026)
6 North America
6.1 North America Lipid-lowering Agent by Country
6.1.1 North America Lipid-lowering Agent Sales by Country
6.1.2 North America Lipid-lowering Agent Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Lipid-lowering Agent Market Facts & Figures by Type
6.3 North America Lipid-lowering Agent Market Facts & Figures by Application
7 Europe
7.1 Europe Lipid-lowering Agent by Country
7.1.1 Europe Lipid-lowering Agent Sales by Country
7.1.2 Europe Lipid-lowering Agent Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Lipid-lowering Agent Market Facts & Figures by Type
7.3 Europe Lipid-lowering Agent Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Lipid-lowering Agent by Region
8.1.1 Asia Pacific Lipid-lowering Agent Sales by Region
8.1.2 Asia Pacific Lipid-lowering Agent Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Lipid-lowering Agent Market Facts & Figures by Type
8.3 Asia Pacific Lipid-lowering Agent Market Facts & Figures by Application
9 Latin America
9.1 Latin America Lipid-lowering Agent by Country
9.1.1 Latin America Lipid-lowering Agent Sales by Country
9.1.2 Latin America Lipid-lowering Agent Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Lipid-lowering Agent Market Facts & Figures by Type
9.3 Central & South America Lipid-lowering Agent Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Lipid-lowering Agent by Country
10.1.1 Middle East and Africa Lipid-lowering Agent Sales by Country
10.1.2 Middle East and Africa Lipid-lowering Agent Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Lipid-lowering Agent Market Facts & Figures by Type
10.3 Middle East and Africa Lipid-lowering Agent Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Lipid-lowering Agent Products Offered
11.1.5 Pfizer Related Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description and Business Overview
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Lipid-lowering Agent Products Offered
11.2.5 Merck Related Developments
11.3 Teva
11.3.1 Teva Corporation Information
11.3.2 Teva Description and Business Overview
11.3.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Teva Lipid-lowering Agent Products Offered
11.3.5 Teva Related Developments
11.4 Amgen
11.4.1 Amgen Corporation Information
11.4.2 Amgen Description and Business Overview
11.4.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Amgen Lipid-lowering Agent Products Offered
11.4.5 Amgen Related Developments
11.5 Abbott
11.5.1 Abbott Corporation Information
11.5.2 Abbott Description and Business Overview
11.5.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Abbott Lipid-lowering Agent Products Offered
11.5.5 Abbott Related Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Corporation Information
11.6.2 AstraZeneca Description and Business Overview
11.6.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.6.4 AstraZeneca Lipid-lowering Agent Products Offered
11.6.5 AstraZeneca Related Developments
11.7 Novartis
11.7.1 Novartis Corporation Information
11.7.2 Novartis Description and Business Overview
11.7.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Novartis Lipid-lowering Agent Products Offered
11.7.5 Novartis Related Developments
11.8 SUN Pharma
11.8.1 SUN Pharma Corporation Information
11.8.2 SUN Pharma Description and Business Overview
11.8.3 SUN Pharma Sales, Revenue and Gross Margin (2015-2020)
11.8.4 SUN Pharma Lipid-lowering Agent Products Offered
11.8.5 SUN Pharma Related Developments
11.9 Torrent Pharmaceuticals
11.9.1 Torrent Pharmaceuticals Corporation Information
11.9.2 Torrent Pharmaceuticals Description and Business Overview
11.9.3 Torrent Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Torrent Pharmaceuticals Lipid-lowering Agent Products Offered
11.9.5 Torrent Pharmaceuticals Related Developments
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Corporation Information
11.10.2 GlaxoSmithKline Description and Business Overview
11.10.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.10.4 GlaxoSmithKline Lipid-lowering Agent Products Offered
11.10.5 GlaxoSmithKline Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Lipid-lowering Agent Products Offered
11.1.5 Pfizer Related Developments
11.12 JX Pharmaceuticals
11.12.1 JX Pharmaceuticals Corporation Information
11.12.2 JX Pharmaceuticals Description and Business Overview
11.12.3 JX Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.12.4 JX Pharmaceuticals Products Offered
11.12.5 JX Pharmaceuticals Related Developments
11.13 Aurobindo Pharma
11.13.1 Aurobindo Pharma Corporation Information
11.13.2 Aurobindo Pharma Description and Business Overview
11.13.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Aurobindo Pharma Products Offered
11.13.5 Aurobindo Pharma Related Developments
11.14 Abbvie
11.14.1 Abbvie Corporation Information
11.14.2 Abbvie Description and Business Overview
11.14.3 Abbvie Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Abbvie Products Offered
11.14.5 Abbvie Related Developments
11.15 Cerenis Therapeutics
11.15.1 Cerenis Therapeutics Corporation Information
11.15.2 Cerenis Therapeutics Description and Business Overview
11.15.3 Cerenis Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Cerenis Therapeutics Products Offered
11.15.5 Cerenis Therapeutics Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Lipid-lowering Agent Market Estimates and Projections by Region
12.1.1 Global Lipid-lowering Agent Sales Forecast by Regions 2021-2026
12.1.2 Global Lipid-lowering Agent Revenue Forecast by Regions 2021-2026
12.2 North America Lipid-lowering Agent Market Size Forecast (2021-2026)
12.2.1 North America: Lipid-lowering Agent Sales Forecast (2021-2026)
12.2.2 North America: Lipid-lowering Agent Revenue Forecast (2021-2026)
12.2.3 North America: Lipid-lowering Agent Market Size Forecast by Country (2021-2026)
12.3 Europe Lipid-lowering Agent Market Size Forecast (2021-2026)
12.3.1 Europe: Lipid-lowering Agent Sales Forecast (2021-2026)
12.3.2 Europe: Lipid-lowering Agent Revenue Forecast (2021-2026)
12.3.3 Europe: Lipid-lowering Agent Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Lipid-lowering Agent Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Lipid-lowering Agent Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Lipid-lowering Agent Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Lipid-lowering Agent Market Size Forecast by Region (2021-2026)
12.5 Latin America Lipid-lowering Agent Market Size Forecast (2021-2026)
12.5.1 Latin America: Lipid-lowering Agent Sales Forecast (2021-2026)
12.5.2 Latin America: Lipid-lowering Agent Revenue Forecast (2021-2026)
12.5.3 Latin America: Lipid-lowering Agent Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Lipid-lowering Agent Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Lipid-lowering Agent Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Lipid-lowering Agent Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Lipid-lowering Agent Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Lipid-lowering Agent Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Lipid-lowering Agent Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Lipid-lowering Agent Market Segments
Table 2. Ranking of Global Top Lipid-lowering Agent Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Lipid-lowering Agent Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Niaci
Table 5. Major Manufacturers of Acipimox
Table 6. Major Manufacturers of Fibrates
Table 7. Major Manufacturers of Others
Table 8. Global Lipid-lowering Agent Market Size Growth Rate by Application 2020-2026 (K Units)
Table 9. Global Lipid-lowering Agent Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 10. Global Lipid-lowering Agent Sales by Regions 2015-2020 (K Units)
Table 11. Global Lipid-lowering Agent Sales Market Share by Regions (2015-2020)
Table 12. Global Lipid-lowering Agent Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Lipid-lowering Agent Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Lipid-lowering Agent Sales Share by Manufacturers (2015-2020)
Table 15. Global Lipid-lowering Agent Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Lipid-lowering Agent by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lipid-lowering Agent as of 2019)
Table 17. Lipid-lowering Agent Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Lipid-lowering Agent Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Lipid-lowering Agent Price (2015-2020) (USD/Unit)
Table 20. Lipid-lowering Agent Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Lipid-lowering Agent Product Type
Table 22. Date of International Manufacturers Enter into Lipid-lowering Agent Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Lipid-lowering Agent Sales by Type (2015-2020) (K Units)
Table 25. Global Lipid-lowering Agent Sales Share by Type (2015-2020)
Table 26. Global Lipid-lowering Agent Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Lipid-lowering Agent Revenue Share by Type (2015-2020)
Table 28. Lipid-lowering Agent Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global Lipid-lowering Agent Sales by Application (2015-2020) (K Units)
Table 30. Global Lipid-lowering Agent Sales Share by Application (2015-2020)
Table 31. North America Lipid-lowering Agent Sales by Country (2015-2020) (K Units)
Table 32. North America Lipid-lowering Agent Sales Market Share by Country (2015-2020)
Table 33. North America Lipid-lowering Agent Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Lipid-lowering Agent Revenue Market Share by Country (2015-2020)
Table 35. North America Lipid-lowering Agent Sales by Type (2015-2020) (K Units)
Table 36. North America Lipid-lowering Agent Sales Market Share by Type (2015-2020)
Table 37. North America Lipid-lowering Agent Sales by Application (2015-2020) (K Units)
Table 38. North America Lipid-lowering Agent Sales Market Share by Application (2015-2020)
Table 39. Europe Lipid-lowering Agent Sales by Country (2015-2020) (K Units)
Table 40. Europe Lipid-lowering Agent Sales Market Share by Country (2015-2020)
Table 41. Europe Lipid-lowering Agent Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Lipid-lowering Agent Revenue Market Share by Country (2015-2020)
Table 43. Europe Lipid-lowering Agent Sales by Type (2015-2020) (K Units)
Table 44. Europe Lipid-lowering Agent Sales Market Share by Type (2015-2020)
Table 45. Europe Lipid-lowering Agent Sales by Application (2015-2020) (K Units)
Table 46. Europe Lipid-lowering Agent Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Lipid-lowering Agent Sales by Region (2015-2020) (K Units)
Table 48. Asia Pacific Lipid-lowering Agent Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Lipid-lowering Agent Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Lipid-lowering Agent Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Lipid-lowering Agent Sales by Type (2015-2020) (K Units)
Table 52. Asia Pacific Lipid-lowering Agent Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Lipid-lowering Agent Sales by Application (2015-2020) (K Units)
Table 54. Asia Pacific Lipid-lowering Agent Sales Market Share by Application (2015-2020)
Table 55. Latin America Lipid-lowering Agent Sales by Country (2015-2020) (K Units)
Table 56. Latin America Lipid-lowering Agent Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Lipid-lowering Agent Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Lipid-lowering Agent Revenue Market Share by Country (2015-2020)
Table 59. Latin America Lipid-lowering Agent Sales by Type (2015-2020) (K Units)
Table 60. Latin America Lipid-lowering Agent Sales Market Share by Type (2015-2020)
Table 61. Latin America Lipid-lowering Agent Sales by Application (2015-2020) (K Units)
Table 62. Latin America Lipid-lowering Agent Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Lipid-lowering Agent Sales by Country (2015-2020) (K Units)
Table 64. Middle East and Africa Lipid-lowering Agent Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Lipid-lowering Agent Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Lipid-lowering Agent Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Lipid-lowering Agent Sales by Type (2015-2020) (K Units)
Table 68. Middle East and Africa Lipid-lowering Agent Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Lipid-lowering Agent Sales by Application (2015-2020) (K Units)
Table 70. Middle East and Africa Lipid-lowering Agent Sales Market Share by Application (2015-2020)
Table 71. Pfizer Corporation Information
Table 72. Pfizer Description and Major Businesses
Table 73. Pfizer Lipid-lowering Agent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 74. Pfizer Product
Table 75. Pfizer Recent Development
Table 76. Merck Corporation Information
Table 77. Merck Description and Major Businesses
Table 78. Merck Lipid-lowering Agent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Merck Product
Table 80. Merck Recent Development
Table 81. Teva Corporation Information
Table 82. Teva Description and Major Businesses
Table 83. Teva Lipid-lowering Agent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Teva Product
Table 85. Teva Recent Development
Table 86. Amgen Corporation Information
Table 87. Amgen Description and Major Businesses
Table 88. Amgen Lipid-lowering Agent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Amgen Product
Table 90. Amgen Recent Development
Table 91. Abbott Corporation Information
Table 92. Abbott Description and Major Businesses
Table 93. Abbott Lipid-lowering Agent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Abbott Product
Table 95. Abbott Recent Development
Table 96. AstraZeneca Corporation Information
Table 97. AstraZeneca Description and Major Businesses
Table 98. AstraZeneca Lipid-lowering Agent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. AstraZeneca Product
Table 100. AstraZeneca Recent Development
Table 101. Novartis Corporation Information
Table 102. Novartis Description and Major Businesses
Table 103. Novartis Lipid-lowering Agent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Novartis Product
Table 105. Novartis Recent Development
Table 106. SUN Pharma Corporation Information
Table 107. SUN Pharma Description and Major Businesses
Table 108. SUN Pharma Lipid-lowering Agent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. SUN Pharma Product
Table 110. SUN Pharma Recent Development
Table 111. Torrent Pharmaceuticals Corporation Information
Table 112. Torrent Pharmaceuticals Description and Major Businesses
Table 113. Torrent Pharmaceuticals Lipid-lowering Agent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. Torrent Pharmaceuticals Product
Table 115. Torrent Pharmaceuticals Recent Development
Table 116. GlaxoSmithKline Corporation Information
Table 117. GlaxoSmithKline Description and Major Businesses
Table 118. GlaxoSmithKline Lipid-lowering Agent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. GlaxoSmithKline Product
Table 120. GlaxoSmithKline Recent Development
Table 121. HanAll BioPharma Corporation Information
Table 122. HanAll BioPharma Description and Major Businesses
Table 123. HanAll BioPharma Lipid-lowering Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. HanAll BioPharma Product
Table 125. HanAll BioPharma Recent Development
Table 126. JX Pharmaceuticals Corporation Information
Table 127. JX Pharmaceuticals Description and Major Businesses
Table 128. JX Pharmaceuticals Lipid-lowering Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 129. JX Pharmaceuticals Product
Table 130. JX Pharmaceuticals Recent Development
Table 131. Aurobindo Pharma Corporation Information
Table 132. Aurobindo Pharma Description and Major Businesses
Table 133. Aurobindo Pharma Lipid-lowering Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 134. Aurobindo Pharma Product
Table 135. Aurobindo Pharma Recent Development
Table 136. Abbvie Corporation Information
Table 137. Abbvie Description and Major Businesses
Table 138. Abbvie Lipid-lowering Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 139. Abbvie Product
Table 140. Abbvie Recent Development
Table 141. Cerenis Therapeutics Corporation Information
Table 142. Cerenis Therapeutics Description and Major Businesses
Table 143. Cerenis Therapeutics Lipid-lowering Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 144. Cerenis Therapeutics Product
Table 145. Cerenis Therapeutics Recent Development
Table 146. Global Lipid-lowering Agent Sales Forecast by Regions (2021-2026) (K Units)
Table 147. Global Lipid-lowering Agent Sales Market Share Forecast by Regions (2021-2026)
Table 148. Global Lipid-lowering Agent Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 149. Global Lipid-lowering Agent Revenue Market Share Forecast by Regions (2021-2026)
Table 150. North America: Lipid-lowering Agent Sales Forecast by Country (2021-2026) (K Units)
Table 151. North America: Lipid-lowering Agent Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Europe: Lipid-lowering Agent Sales Forecast by Country (2021-2026) (K Units)
Table 153. Europe: Lipid-lowering Agent Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Asia Pacific: Lipid-lowering Agent Sales Forecast by Region (2021-2026) (K Units)
Table 155. Asia Pacific: Lipid-lowering Agent Revenue Forecast by Region (2021-2026) (US$ Million)
Table 156. Latin America: Lipid-lowering Agent Sales Forecast by Country (2021-2026) (K Units)
Table 157. Latin America: Lipid-lowering Agent Revenue Forecast by Country (2021-2026) (US$ Million)
Table 158. Middle East and Africa: Lipid-lowering Agent Sales Forecast by Country (2021-2026) (K Units)
Table 159. Middle East and Africa: Lipid-lowering Agent Revenue Forecast by Country (2021-2026) (US$ Million)
Table 160. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 161. Key Challenges
Table 162. Market Risks
Table 163. Main Points Interviewed from Key Lipid-lowering Agent Players
Table 164. Lipid-lowering Agent Customers List
Table 165. Lipid-lowering Agent Distributors List
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Lipid-lowering Agent Product Picture
Figure 2. Global Lipid-lowering Agent Sales Market Share by Type in 2020 & 2026
Figure 3. Niaci Product Picture
Figure 4. Acipimox Product Picture
Figure 5. Fibrates Product Picture
Figure 6. Others Product Picture
Figure 7. Global Lipid-lowering Agent Sales Market Share by Application in 2020 & 2026
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Lipid-lowering Agent Report Years Considered
Figure 12. Global Lipid-lowering Agent Market Size 2015-2026 (US$ Million)
Figure 13. Global Lipid-lowering Agent Sales 2015-2026 (K Units)
Figure 14. Global Lipid-lowering Agent Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Lipid-lowering Agent Sales Market Share by Region (2015-2020)
Figure 16. Global Lipid-lowering Agent Sales Market Share by Region in 2019
Figure 17. Global Lipid-lowering Agent Revenue Market Share by Region (2015-2020)
Figure 18. Global Lipid-lowering Agent Revenue Market Share by Region in 2019
Figure 19. Global Lipid-lowering Agent Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Lipid-lowering Agent Revenue in 2019
Figure 21. Lipid-lowering Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Lipid-lowering Agent Sales Market Share by Type (2015-2020)
Figure 23. Global Lipid-lowering Agent Sales Market Share by Type in 2019
Figure 24. Global Lipid-lowering Agent Revenue Market Share by Type (2015-2020)
Figure 25. Global Lipid-lowering Agent Revenue Market Share by Type in 2019
Figure 26. Global Lipid-lowering Agent Market Share by Price Range (2015-2020)
Figure 27. Global Lipid-lowering Agent Sales Market Share by Application (2015-2020)
Figure 28. Global Lipid-lowering Agent Sales Market Share by Application in 2019
Figure 29. Global Lipid-lowering Agent Revenue Market Share by Application (2015-2020)
Figure 30. Global Lipid-lowering Agent Revenue Market Share by Application in 2019
Figure 31. North America Lipid-lowering Agent Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Lipid-lowering Agent Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Lipid-lowering Agent Sales Market Share by Country in 2019
Figure 34. North America Lipid-lowering Agent Revenue Market Share by Country in 2019
Figure 35. U.S. Lipid-lowering Agent Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Lipid-lowering Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Lipid-lowering Agent Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Lipid-lowering Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Lipid-lowering Agent Market Share by Type in 2019
Figure 40. North America Lipid-lowering Agent Market Share by Application in 2019
Figure 41. Europe Lipid-lowering Agent Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Lipid-lowering Agent Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Lipid-lowering Agent Sales Market Share by Country in 2019
Figure 44. Europe Lipid-lowering Agent Revenue Market Share by Country in 2019
Figure 45. Germany Lipid-lowering Agent Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Lipid-lowering Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Lipid-lowering Agent Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Lipid-lowering Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Lipid-lowering Agent Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Lipid-lowering Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Lipid-lowering Agent Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Lipid-lowering Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Lipid-lowering Agent Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Lipid-lowering Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Lipid-lowering Agent Market Share by Type in 2019
Figure 56. Europe Lipid-lowering Agent Market Share by Application in 2019
Figure 57. Asia Pacific Lipid-lowering Agent Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Lipid-lowering Agent Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Lipid-lowering Agent Sales Market Share by Region in 2019
Figure 60. Asia Pacific Lipid-lowering Agent Revenue Market Share by Region in 2019
Figure 61. China Lipid-lowering Agent Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Lipid-lowering Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Lipid-lowering Agent Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Lipid-lowering Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Lipid-lowering Agent Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Lipid-lowering Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Lipid-lowering Agent Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Lipid-lowering Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Lipid-lowering Agent Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Lipid-lowering Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Lipid-lowering Agent Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Lipid-lowering Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Lipid-lowering Agent Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Lipid-lowering Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Lipid-lowering Agent Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Lipid-lowering Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Lipid-lowering Agent Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Lipid-lowering Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Lipid-lowering Agent Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Lipid-lowering Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Lipid-lowering Agent Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Lipid-lowering Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Lipid-lowering Agent Market Share by Type in 2019
Figure 84. Asia Pacific Lipid-lowering Agent Market Share by Application in 2019
Figure 85. Latin America Lipid-lowering Agent Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Lipid-lowering Agent Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Lipid-lowering Agent Sales Market Share by Country in 2019
Figure 88. Latin America Lipid-lowering Agent Revenue Market Share by Country in 2019
Figure 89. Mexico Lipid-lowering Agent Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Lipid-lowering Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Lipid-lowering Agent Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Lipid-lowering Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Lipid-lowering Agent Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Lipid-lowering Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Lipid-lowering Agent Market Share by Type in 2019
Figure 96. Latin America Lipid-lowering Agent Market Share by Application in 2019
Figure 97. Middle East and Africa Lipid-lowering Agent Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Lipid-lowering Agent Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Lipid-lowering Agent Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Lipid-lowering Agent Revenue Market Share by Country in 2019
Figure 101. Turkey Lipid-lowering Agent Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Lipid-lowering Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Lipid-lowering Agent Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Lipid-lowering Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Lipid-lowering Agent Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Lipid-lowering Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Lipid-lowering Agent Market Share by Type in 2019
Figure 108. Middle East and Africa Lipid-lowering Agent Market Share by Application in 2019
Figure 109. North America Lipid-lowering Agent Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. North America Lipid-lowering Agent Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Lipid-lowering Agent Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Europe Lipid-lowering Agent Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Lipid-lowering Agent Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Asia Pacific Lipid-lowering Agent Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Lipid-lowering Agent Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Latin America Lipid-lowering Agent Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Lipid-lowering Agent Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Middle East and Africa Lipid-lowering Agent Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
コレステロール低下生物学的薬剤の世界市場（～2026年） The cholesterol lowering biologic drugs offers a new, revolutionary alternative for people fighting with cholesterol with the same old treatments. The old method of treating cholesterol elevated levels includes a change in diet and consuming statin pills to prevent the body from making more bad chol…- 脂質異常症治療の世界市場（～2026年） Lipid disorder means the people high blood levels of low-density lipoprotein (LDL) cholesterol, fats called triglycerides,. Several biopharma companies are focusing on developing effective solutions for treating lipid disorders. Companies involved in lipid disorder treatment market include Teva Phar…
- コレステロール降下薬の世界市場（～2026年） Market Analysis and Insights: Global Cholesterol-Lowering Drugs Market The global Cholesterol-Lowering Drugs market size is projected to reach US$ 17960 million by 2026, from US$ 17440 million in 2020, at a CAGR of 2.8%% during 2021-2026. Global Cholesterol-Lowering Drugs Scope and Market Size Chole…
- ポイントオブケア脂質検査の世界市場（～2026年） Growing geriatric population base, increasing global prevalence of cardiovascular diseases, and rising healthcare awareness due to patient education are the driving forces for the PoC Lipid Test industry growth during the forecast period. Furthermore, continuous efforts by the government to reduce h…
- 脂質パネル検査の世界市場（～2026年） Lipid Panel Test (LPT), or total lipid profile or lipid panel is a panel of blood tests that serves as an initial broad medical screening tool for abnormalities in lipids, such as cholesterol and triglycerides. This test enables diagnosis of lipid disorders along with risk for coronary heart disease…